For Société Générale, Strategy Reshuffling Pays Off
Our estimates suggest a midcycle return on tangible equity of around 6.4% for Société Générale, materially lower than our estimated cost of capital of 11.5%, which includes a 0.5% country risk premium ...
Viking Therapeutics, Inc.: Viking Therapeutics Reports Fourth Quarter and Year-End 2024 Financial Results and Provides Corporate Update
Conference call scheduled for 4:30 p.m. ET today Initiation of Phase 3 Studies for Subcutaneous VK2735 for Obesity Planned for 2Q25 Phase 2 VENTURE-Oral Dosing Trial ...
Artificial Lift System Market: Enhancing Well Productivity And Efficiency In Oil & Gas Extraction
Artificial Lift System Market projected to reach US$ 55.3 billion by 2030 | North America Dominate Region by US, Canada Improving ...
Peak Earnings With Few Avenues for Earnings Growth to Justify Valuation
We expect REA Group’s growth to be primarily driven by growth in yield, or listing fees, within its residential division, rather than from market share gains. REA Group’s market share versus Domain in ...
Haemonetics Corporation (HAE) Q3 2025 Earnings Call Transcript
Q3 2025 Earnings Conference Call February 6, 2025 8:30 AM ETCompany ParticipantsOlga Guyette - Vice President, ...
Earnings call transcript: Haemonetics Q3 2024 sees EPS beat, stock drops
Haemonetics Corporation (market cap: $3.23B) reported its third-quarter earnings for fiscal year 2024, surpassing analysts' expectations with an adjusted earnings per share (EPS) of $1.19, slightly ...